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ABSTRACT Protein I (PI), the major outer membrane
protein of Neisseria gonorrhoeae, is a porin and occurs in two
major immunochemical classes, A and B. By using shuttle
mutagenesis to insert a selectable marker close to the PI
structural gene, evidence was obtained from transformation
experiments to demonstrate that the PI structural gene is
equivalent to the defmed locus nmp and that the genes for PI
class A and PI class B are alleles of the same locus. The PI class
B gene of strain MS11 was cloned and sequenced, and
comparison of this sequence with the gene sequence of PI class
A of FA19 revealed a number of regions of significant diver-
gence. By selection for the closely linked marker in transfor-
mations between the two strains, a series of strains with a
hybrid PI was obtained. Analysis of these strains with mono-
clonal antibodies and oligonucleotides specific to PI class A or
PI class B elucidated the nature and location of some of the
surface-exposed epitopes, a thorough characterization ofwhich
is a prerequisite for understanding the role of PI in gonococcal
pathogenesis and its possible use as a component of a vaccine.
Protein I (PI) of Neisseria gonorrhoeae, the major outer
membrane protein, has a number of properties that indicate
its potential as a component of a vaccine. Apart from its
well-documented role as an anion-selective porin (1-3), PI is
expressed on the surface of all gonococci, is highly antigenic
in vivo (4), and has the interesting ability to insert into cell and
artificial membranes directly from gonococcal cells (5, 6).
Compared to certain other highly variable surface-exposed
components of the gonococcus-notably, pilin (7), protein II
(8), and LOS (lipooligosaccharide) (9)-PI is antigenically
stable in vitro. It occurs in two major immunochemical
classes, A and B (PIA and PIB), each composed of multiple
serovars (10). The two classes of PI differ in their apparent
molecular weight, their susceptibility to proteolysis (11), and
their reactivity with polyclonal and monoclonal antibodies
(12). Clinical isolates always contain either PIA or PIB, but
never both (10). Although PIA/B hybrids can be constructed
in the laboratory (13), they virtually never occur in nature
(10). Since systemic gonococcal infections are usually caused
by PIA strains and PIB strains are more commonly associ-
ated with local infections (14), PIA and PIB may play
different roles in the pathogenicity of gonococci.
A major advance in the understanding of gonococcal PI
was achieved by the cloning of the structural gene for both
PIB (15) and PIA (16). The nucleotide and amino acid
sequences of the two contained a large amount of homology
interspersed with regions of significant diversity. Hybridiza-
tion studies indicated that there is only a single PI structural
gene in the gonococcal genome (15, 16), suggesting that the
genes for PIA and PIB may be alleles of the same locus.
In this paper we report the use ofa closely linked selectable
marker introduced by shuttle mutagenesis (17) to confirm the
allelic nature of the PI structural genes, to demonstrate their
equivalence to the defined locus nmp (18), and to construct
PIA/B hybrid genes by transformation. Analysis of the hy-
brid proteins encoded by these genes elucidated the approx-
imate locations of epitopes for various PI-specific mono-
clonal antibodies.
MATERIALS AND METHODS
Bacterial Strains and Plasmids. N. gonorrhoeae strains
used in this study were FA19 (PIA) (19), MS11 (PIB) (20), and
FA6149 (PIA/B) (13). Escherichia coli strains HB101 (21) and
Y1090 (22) have been described. E. coli strains used for
shuttle mutagenesis were RDP146 (pTCA), W3110polA
(pOX38::mTn3Cm-3), and NS2114Sm (17). Plasmids used
were pHSS6 (17) and pGEM-3, obtained from Promega
Biotec (Madison, WI).
Medium and Growth Conditions. N. gonorrhoeae strains
were grown on GC-base medium (Difco) containing Kellogg's
supplements I and II (23) in a 5% C02/95% air atmosphere.
The following antibiotics were used when necessary: chlor-
amphenicol (1 ,ug/ml for FA19 and 10 zg/ml for MS11),
spectinomycin (100 ,ag/ml), and streptomycin (100 ,tg/ml).
E. coli strains were grown on Luria medium (21) with the
following additions when appropriate: ampicillin (50 ,ug/ml),
chloramphenicol (30 ,ug/ml), tetracycline (10 ,ug/ml), ka-
namycin (40 ,ug/ml), and streptomycin (100 ,g/ml).
Transformation ofN. gonorrhoeae. N. gonorrhoeae strains
were transformed by the method of Biswas et al. (24). Cells
were incubated for phenotypic expression of antibiotic resis-
tance for 5 hr either in GC-base broth before plating or on
GC-base agar before addition of a soft agar overlay contain-
ing the antibiotic. When using FA19 as the recipient and
selecting for chloramphenicol resistance (Cmr) the antibiotic
at 1 ug/ml was used, whereas for MS11 the antibiotic at 10
,ug/ml was used.
Colony Immunoblotting. Bacterial strains were assayed for
binding of monoclonal antibodies by a modification of the
method of Cannon et al. (25). A concentrated suspension of
cells in GC-base broth was transferred to nitrocellulose by
using a filtration manifold and lysed in chloroform vapor. The
filter was soaked in TBS (10 mM Tris HCl, pH 7.5/150 mM
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NaCi) containing 5% (wt/vol) nonfat dried milk, incubated in
TBS containing the appropriate antibody, and then washed in
TBS. After incubation in alkaline phosphatase-conjugated
anti-mouse IgG as secondary antibody (Sigma) and further
washing, the filter was developed by using nitroblue tetra-
zolium and 5-bromo-4-chloro-3-indolyl phosphate (Bethesda
Research Laboratories) according to the directions of the
manufacturer. The monoclonal antibodies used were 4A12,
4G5, 2F12, 6D9, 5G9, 5D1 (10), 1D3 (26), and SM101 (27), all
of which are PIA-specific, and iF5, 3C8, 2D4, and 2H1 (10),
which are PIB-specific. All antibodies except SM101 were
kindly supplied in ascites fluid by M. Tam (Genetic Systems)
and were used at dilutions of 1:2000 to 1:10,000. SM101 was
kindly provided by J. Heckels (University of Southampton).
DNA Techniques. Gonococcal genomic DNA was prepared
by the method of Stem et al. (28). Preparation of plasmid
DNA and transformation into E. coli were performed as
described by Maniatis et al. (21). Restriction endonucleases,
DNA polymerase I Klenow fragment, T4 DNA ligase, and
polynucleotide kinase were obtained from either Bethesda
Research Laboratories or New England Biolabs and were
used according to the instructions of the manufacturer.
Oligonucleotides were synthesized and used for hybridiza-
tion as described (16). For Agtll cloning, 400- to 700-base-
pair (bp) Hinfi-digested fragments of MS11 DNA were
gel-purified, end-filled by using Klenow fragment, and ligated
with EcoRI linkers (Bethesda Research Laboratories). These
fragments were then ligated with EcoRI-digested Agtll and
the ligation mixture was packaged and used to infect E. coli
Y1090. Plaques were transferred to nitrocellulose and probed
by hybridization by the methods of Maniatis et al. (21). For
sequencing, fragments were subcloned into M13mp18 (29)
and sequencing was performed with the sequencing kit
supplied by United States Biochemical (Cleveland, OH)
according to the instructions of the manufacturer.
Shuttle Mutagenesis. Shuttle mutagenesis was performed
by a modification of the method of Seifert et al. (17, 30). The
target DNA was subcloned into pHSS6 and introduced into
RDP146 (pTCA) by transformation, and then pOX38::
mTn3Cm-3 was introduced by conjugation. Transconjugants
were grown overnight at 30°C to allow transposition to occur
and then grown several hours at 37°C. A "pool" of trans-
conjugants (1000 colonies) was resuspended and used as the
donor in conjugation with NS2114Sm, in which plasmid
cointegrates, formed as an intermediate in transposition
events into the target plasmid, are resolved (17). The trans-
poson thus inserted is stable since the transposase function,
which was provided in trans on plasmid pTCA, is no longer
present. The mini-transposon used in this case was mTn3Cm-
3, in which the bla gene of Tn3 is replaced by the chloram-
phenicol acetyltransferase (CAT) gene. A full description of
the development of this system for gonococci will be pub-
lished separately (H.S.S., R. Ajioka, M.V. Ho, F. Heffron,
M.S., unpublished work). Use of CAT for experiments in N.
gonorrhoeae was approved by the local biosafety committees
at the University of North Carolina at Chapel Hill and The
Research Institute of Scripps Clinic.
RESULTS
Insertion of a Selectable Marker Adjacent to the PI Gene in
FA19. The 900-bp Sau3AI fragment of pUNC3 (16), contain-
ing the first 45 codons of the PI gene of FA19 and upstream
sequences, was ligated with BamHI-digested pHSS6 to form
the plasmid pNCS2 (Fig. 1). This plasmid was then subjected
to shuttle mutagenesis. After mapping the mTn3Cm-3 inser-
tion sites within the 900-bp Sau3AI fragment of pNCS2, five
such constructs with mTn3Cm-3 at various sites were di-
gested with Not I, which releases the total insert as a linear















FIG. 1. Insertion of mTn3-CAT (CAT above an open inverted
triangle) adjacent to the PI structural gene of FA19. The thick line
represents the vector pHSS6 DNA. mTn3-CAT is 1.66 kilobases long
and is not drawn to scale. The position of the PI gene on the genome
of FA19 CAT D1 is indicated by the bar above the line, with the
hatched box denoting the signal sequence. PF', portion of the PI gene
present in the cloned constructs; N, Not I; B, BamHI; S, Sau3AI.
plasmid, pNCS32 (Fig. 1), transformed FA19 to Cmr, at a
frequency of 10'-. The site of insertion of mTn3Cm-3 in
pNCS32 was -300 bp upstream of the PIA gene promoter
sequences, whereas the insertion sites in the other four
plasmids were all closer to, but not within, the PI gene. The
location of mTn3Cm-3 in the genome of the transformant
FA19 CAT D1 (Fig. 1) was confirmed by Southern hybrid-
ization (data not shown).
Evidence That the nmp Locus Is the PI Structural Gene and
That the PIA and PIB Genes Are Alleles. Studies (18, 31) have
shown that the nmp locus, which affects the molecular weight
and antigenicity of PI, is closely linked on the gonococcal
genome to the antibiotic resistance markers str and spc, in
the order str-spc-nmp, with cotransformation frequencies of
5% for str and nmp, and =23% for spc and nmp. To determine
whether the CAT marker in FA19 CAT D1, adjacent to the
PI structural gene, showed the same linkage pattern as the
nmp locus, reciprocal crosses were performed between the
strains FA130 (Strr Spcr Cms) (32) and FA19 CAT D1 (Strs
Spcs Cm%, where Str is streptomycin, Spc is spectinomycin
and s is sensitivity. When FA130 DNA was used to transform
FA19 CAT D1, selecting for either Strr or Spcr, cotransfor-
mation frequencies were 26% (99/383) for spc and CAT and
7.5% (40/537) for str and CAT. In the reciprocal cross,
selecting for Cmr, the cotransformation frequencies were
10% (11/111) for spc and CAT and 1% (1/111) for str and
CAT. Analysis of crossover classes confirmed that the gene
order was str ... spc ... CAT. These data demonstrated
that the CAT gene was linked to the str and spc markers in
the same way as the nmp locus, providing strong evidence
that the nmp locus is the structural gene for PI.
In another cross, FA19 CAT D1 DNA was used to
transform the PIB strain MS11, and the transformants were
selected for Cmr. Among 45 transformants, 24 acquired the
donor PIA, 13 retained the recipient PIB, and 8 expressed
hybrid PIA/B proteins, as detected by colony immunoblot-
ting. The replacement of the recipient PIB by the PIA of the
donor when selecting for the closely linked CAT gene
confirmed the allelic nature of these genes, and the frequent
occurrence of hybrid proteins suggested that the sequence
homology between the two alleles allowed intragenic recom-
bination to occur. Detailed analysis of these PI hybrid strains
depended on knowledge of the PIB sequence of MS11, which
was cloned and sequenced.
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FIG. 2. Fragments of MS11 DNA cloned for the sequencing of
the PI gene. The position of the PI gene is indicated by the bar above
the line, with the shaded box denoting the signal sequence. The
locations of the sequences of oligonucleotides NC1 and NC12 are
shown. The larger fragment was cloned into the vector plasmid
pGEM-3 and the smaller fragment into Agt11 to give constructs with
the indicated designations. Hf, Hinfl; K, Kpn I; S, Sau3AI; Hc,
HincII.
Cloning and Sequencing of the PI Gene of MS11. Since
intact gonococcal PI genes apparently cannot be cloned in E.
coli (15, 16), the strategy (15, 16) of cloning fragments that
together contain the complete gene sequence was adopted for
the MS11 PI gene. A DNA fragment from within the PI gene
ofthe strain FA6149, characterized as having a hybrid PI (13),
was cloned and sequenced, and the sequence revealed the
presence of a Kpn I site in the PIB portion of the sequence,
-300 bp from the start of the gene. Oligonucleotides NC12
(Fig. 2), derived from the PIB gene sequence downstream of
the Kpn I site, and NC1 (Fig. 2), derived from the gene
sequence corresponding to the N terminus ofthe protein (16),
were used as probes in Southern hybridization to confirm the
presence of the Kpn I site in the MS11 PI gene (data not
shown). HB101 colonies containing Kpn I/HincII-digested
MS11 DNA cloned into the vector plasmid pGEM-3 were
probed with these oligonucleotides, and colonies hybridizing
with NC12 were detected and found to contain a plasmid with
a 1.8-kilobase Kpn 1-HinclI fragment that hybridized with
NC12. This plasmid was designated pUNCH22 (Fig. 2).
However, despite repeated attempts, no colonies hybridizing
with NC1 were detected. Since NC1 hybridized with a 750-bp
Kpn 1-HincII fragment of MS11 genomic DNA in Southern
hybridization (data not shown), the problem apparently was
not one of size, but more likely the eipression of the PI gene
portion on this fragment that, in a high-copy-number vector,
was lethal for HB101. For this reason the remaining portion
of the MS11 PI gene was isolated as a 540-bp Hinfl fragment
in Agtll, by using oligonucleotide NC1 as a probe. This clone
was designated Agtll.NC1 (Fig. 2). The 540-bp Hinfl frag-
ment ofAgtl1.NC1 and the 750-bp Kpn I-Sau3AI fragment of
pUNCH22 were digested further, subcloned, and sequenced.
The sequence is shown in Fig. 3 and predicts a protein of 350
amino acids, of which the first 19 are the putative signal
peptide. The sequence is closely homologous to the PI gene
sequence of R10 (15), with only 17 differences in the pre-
dicted amino acid sequences of the two proteins. A compar-
ison of the PI gene sequences ofFA19 (16) and MS11 reveals
80% nucleotide sequence similarity. A comparison of the
predicted amino acid sequences of PIA (FA19) and PIB
(MS11) is presented in Fig. 4 and shows a number of regions
of significant diversity interspersed with long regions of
homology. Some of the regions of diversity presumably cor-
respond to surface-exposed antigenic portions of the pro-
tein, since PI-specific monoclonal antibodies raised against
whole gonococcal cells are never cross-reactive between
PIA and PIB (10).
Construction and Analysis of PIA/B Hybrid Strains. Fur-
ther PIA/B hybrids were constructed by transforming MS11
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FIG. 3. DNA sequence of the PIB gene of MS11. The predicted amino acid sequence is shown above the DNA sequence, with the signal
peptide indicated. The putative promoter sequences (- 35 and - 10) and the ribosome binding site (RBS) are shown, as are the relevant restriction
enzyme sites. The last base number of each line is shown on the right. To denote differences from the PIB sequence of R10 (15), bases (other
than those making up a restriction enzyme site) are underlined and amino acids are circled. The single-letter amino acid code is used.
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FIG. 4. Comparison of the amino acid sequences of FA19 PIA and MS11 PIB and the structure of hybrid PI genes. PIA gene sequence is
denoted by the open bar and PIB by the solid bar. Above and below the PI genes are the comparisons of amino acid sequence, a vertical line
corresponding to a single difference and a solid block corresponding to a contiguous stretch of differences. The number of amino acid residues
is shown on the upper scale and the base-pair number is shown on the lower scale. The oligonucleotides used to analyze the hybrids are shown
between the genes, with the dotted line indicating the equivalent position on the other gene. The hybrid gene structures (classes 1-9) are shown,
and regions between oligonucleotide sequences where a crossover occurred are depicted by the slanted locations. The PI serovars ofthe various
hybrid classes are shown in Table 1.
immunoblotting. Among 100 transformants, 10 had a differ-
ent PI from either parent and so were presumed to have a
hybrid PI. These included the 8 strains with a hybrid PI
referred to earlier in Results. In a reciprocal cross, DNA from
a Cmr transformant of MS11 that had retained its PIB was
used to transform FA19, selecting for Cmr, and scoring PI as
before. Among 300 transformants, 3 had a hybrid PI. Among
the 13 hybrid strains, five different hybrid PI serovars were
identified (Table 1). The hybrid strains were then analyzed by
colony hybridization by using a number of PIA- and PIB-
specific oligonucleotides (Table 2 and Fig. 4), to assess which
portions of the hybrid PI genes were PIA sequences and
which were PIB sequences, and nine different classes were
detected by this method (Fig. 4). By analyzing the serovar of
the hybrid PI genes of known structure, the approximate
Table 1. Reactivities (serovars) of hybrid PI strains with
PI-specific monoclonal antibodies
Monoclonal Hybrid class Strain
antibody 1-4 5 6 7-8 9 FA19 MS11
4G5 + + + - + + -
2F12 + + + - + + -
SM101 + - - - + + -
6D9 - - + + + + -
4A12 - - - - + + -
5G9 - - - + + -
5D1 - - - - + + -
1D3 - - - - + + -
iFS - - - + - +
3C8 + + - - + - +
2D4 + + - - - - +
2H1 + + - - - - +
+, Reaction with the monoclonal antibody; -, no reaction with
the monoclonal antibody.
location of the epitopes for these monoclonal antibodies
could then be determined.
The epitopes for the PIA-specific monoclonal antibodies
4G5, 2F12, and SM101, which react with the class 1 hybrid,
must be located near the N terminus ofthe protein, within the
first 60 residues. Comparison of hybrid classes 1, 5, and 6
suggests that the epitope for SM101 lies at least partially in
the region between residues 34 and 60. The N-terminal 60
residues contain significant diversity between PIA and PIB
(Fig. 4) that could account for the specificity of these anti-
bodies. The epitope for 6D9 (PIA-specific), which reacts with
hybrid classes 6-9, lies in the region of the protein between
residues 187 and 250, which also includes regions of signif-
icant diversity between PIA and PIB. The epitopes for 4A12,
5G9, 5D1, and 1D3 (all PIA-specific) were detected only in
the hybrid protein of class 9 and, therefore, presumably are
complex epitopes involving both N-terminal and C-terminal
portions of the protein. This is supported by the observation
Table 2. Oligonucleotides used for analysis of PI hybrids
Oligo- PI
nucleotide Sequence (5' Y3') specificity Location
NC8 GCGTTAAAACCGCTACC A 27-32
NC9 TCGAACCCAAATCAGCG A 34-40
NC11 CGGTGTCGGTCTGCGCC A 299-305
NC12 GATACGGCGAAGGCACT B 182-187
NC13 CAAGGTGCCTCCGTCGC B 61-66
NC14 AAGTGCGCGTCGGCCGT A 87-92
NC15 GACTTGGCGCAACGATAA A 213-219
NC16 GCAGCGTACAATACGCAC B 144-150
NC18 GCAACATTGCCCAACCC A 116-121
NC19 AGGCACTGTTGATAGTGC B 273-279
Location refers to the amino acid residue numbers (where position
1 is the first residue ofthe mature protein) encoded in whole or in part
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that these antibodies do not react well with PIA in an
immunoblot, where the protein is relatively denatured (data
not shown).
Among the four antibodies that react with PIB ofMS11, the
epitope for 1F5, which reacts with hybrid classes 7 and 8, is
located within the N-terminal 60 residues, and the epitopes
for 3C8, 2D4, and 2H1 apparently lie within a central part of
the protein, between residues 150 and 270, which includes a
long stretch of divergent sequence. The epitope for 3C8 is
located slightly upstream of those for 2D4 and 2H1, since the
class 9 hybrid protein reacts with 3C8 only. However, the
epitopes for 2D4 and 2H1 may be relatively complex since
these antibodies do not react with PIB in an immunoblot (data
not shown).
DISCUSSION
PI is an abundant, ever-present, and relatively invariant
structure of the gonococcal outer membrane and, accord-
ingly, the genetics of PI seems to be relatively uncompli-
cated. In this study, we utilized a reporter gene inserted close
to the PI structural gene to demonstrate that PIA and PIB
structural genes are alleles of the same locus, which was
previously identified as nmp (18). The presence of a single PI
gene on the gonococcal genome is consistent with the
observation that naturally occurring strains possess either a
PIA or a PIB protein, but never both, and that their PI
serotype is stably maintained. A comparison of the PIA and
PIB gene and deduced amino acid sequences revealed a high
degree of homology, but regions of significant sequence
divergence were identified. Although PI hybrids do not occur
naturally, the PI hybrids that we constructed survived stably
in vitro. However, the relatively infrequent formation of a
hybrid PI with a PIB N terminus and the surprisingly frequent
occurrence of multiple crossovers within the PI gene suggests
that certain classes of hybrid PI may be favored by gonococci
growing in vitro.
The construction and analysis of PI hybrids allowed us to
determine the approximate location of some of the surface-
exposed portions of the proteins and provided some insight
into their possible secondary and tertiary structures. The
N-terminal regions of both PIA and PIB apparently are
surface-exposed, along with at least one other region in the
central part of each protein. The folding of PIA in the outer
membrane may be such that N-terminal and C-terminal parts
are closely associated on the surface, since epitopes for a
number of PIA-specific monoclonal antibodies were identi-
fied only when both of these portions were present in a hybrid
PI. These models for the conformation of PI in the outer
membrane agree with some aspects of previous models based
on proteolytic cleavage of PI in intact gonococci (11, 33), but
differ from previous suggestions that only the N terminus of
PIA and a central portion of PIB are surface-exposed (11, 34).
Clearly further data are required to elucidate which portions
of PI are surface-exposed, and how they are associated in
trimeric form in the outer membrane. Identification and
characterization of all surface-exposed regions of PI will be
an important step toward the development of a vaccine based
on this protein.
To the best of our knowledge, this is the first description
of shuttle mutagenesis for the introduction of a reporter gene
in the gonococcus. Insertion ofmTn3Cm-3 provided a readily
selectable Cmr phenotype, which was much easier to use than
related constructions containing bla (data not shown). We
attempted to make mutant strains lacking a porin by trans-
forming with other constructions containing mTn3Cm-3
within the PIA structural gene, but were unsuccessful,
presumably because a PI-mutant is not viable (data not
shown). However, this powerful system should be useful for
the mutagenesis of nonessential genes.
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